Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dull Q1 for Cipla Amid Distributor 'Churn' In India

Aug 09 2019

• By Anju Ghangurde

Holding_Arrow — Cipla Reports Muted Q1 But Says Fundamentals Remain Strong • Source: Shutterstock

Related Content

Amgen Fails To Block Cipla’s Generic Cinacalcet In US, And It May Change How Patent Settlements Are Drafted

May 07 2019

Cipla-Alvotech Prime Emerging Markets Push With Humira Biosimilar Deal

Jul 29 2019

Cipla Docks Into China, Manufacturing Plans In Tow

Jul 17 2019

Related Companies

Cipla Limited

Amgen, Inc.

Achaogen, Inc.

Roche Holding AG

Alvotech

AbbVie Inc.

Additional Topics

India Asia Pacific Commercial Strategy Sales & Earnings BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window